CDC : 40 years of prevention

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

CDC : 40 years of prevention

Published Date:

June 1986

Source:

Dateline: CDC ; v. 18, no. 5, rev.

Series:

Dateline: CDC

Language:

English

[PDF-7.60 MB]

This document cannot be previewed automatically as it exceeds 5 MB

Please click the thumbnail image to view the document.

Details:

Alternative Title:

Forty years of prevention

Corporate Authors:

Centers for Disease Control (U.S.)

Document Type:

Newsletter

Place as Subject:

United States

Collection(s):

David J. Sencer CDC Museum

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

GRADE Hepatitis A vaccine for post-exposure prophylaxis in adults >40 years of age

Personal Author:

Nelson, Noele

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group..

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)

Published Date:

3/26/18

Series:

ACIP meeting Hepatitis Vaccines

Description:

Presentations February 2018 Day 1Publication date from document properties.Hepatitis-04-Nelson-508.pdf

File Type:

[PDF - 464.63 KB]
Colonoscopy Screening Among US Adults Aged 40 or Older With a Family History of Colorectal Cancer

Personal Author:

Tsai, Meng-Han; Xirasagar, Sudha; Li, Yi-Jhen; de Groen, Piet C.;

Published Date:

May 21 2015

Source:

Prev Chronic Dis. 12.

Description:

IntroductionColonoscopy screening reduces colorectal cancer (CRC) incidence and mortality. CRC screening is recommended at age 50 for average-risk people. Screening of first-degree relatives of CRC patients is recommended to begin at age 40 or 10 yea...

File Type:

[PDF - 304.80 KB]
Update on recommendations for use of herpes zoster vaccine

Personal Author:

Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases..

Published Date:

August 22, 2014

Series:

MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31

Description:

Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...

Status:

current

File Type:

[PDF - 195.85 KB]
Update on Recommendations for Use of Herpes Zoster Vaccine

Personal Author:

Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

Aug 22 2014

Source:

MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.

Description:

Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...

File Type:

[PDF - 109.32 KB]
Updated ACIP recommendations for use of hepatitis A vaccine and immune globulin for post-exposure prophylaxis and for international travelers

Personal Author:

Link-Gelles, Ruth

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)

Published Date:

7/13/2017

Series:

ACIP meeting Hepatits Vaccines

Description:

Presentations June 2017 Day 1hepatitis-05-Link-Gelles.pdf

File Type:

[PDF - 515.37 KB]